Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
University Malaya Medical Centre, Kuala Lumpur, WP Kuala Lumpur, Malaysia
Seoul National University Hospital, Seoul, Other, Korea, Republic of
Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain
Hospital Universitario Ramón y Cajal, Madrid, Spain
Hospital Clínico Universitario de Valencia, Valencia, Spain
Kantonsspital Münsterlingen, Münsterlingen, Switzerland
University Hospital Zuirch, Zurich, Switzerland
Stadtspital Triemli, Zurich, Switzerland
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
RedCliffe Hospital, Redcliffe, Queensland, Australia
ØNH Legen, Trondheim, Trøndelag, Norway
Namsos Hospital, Nord-Trondelag Hospital Trust, Namsos, Trøndelag, Norway
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.